• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清钙轻微升高对健康受试者和原发性甲状旁腺功能亢进患者甲状旁腺激素免疫异质性的影响。

Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.

作者信息

Ahrén B, Bergenfelz A

机构信息

Department of Medicine, Lund University, Malmö, Sweden.

出版信息

Horm Res. 1995;43(6):294-9. doi: 10.1159/000184315.

DOI:10.1159/000184315
PMID:7607615
Abstract

To study possible influences of a mild increase in serum-ionized calcium concentration that is seen during daily life on circulating parathyroid hormone (PTH) immunoheterogeneity, we used sequence-specific PTH assays to determine serum intact PTH, C-terminal PTH and N-terminal PTH following oral calcium (1.5 g) in healthy subjects (n = 7). This was also performed in patients with primary hyperparathyroidism (pHPT; n = 10) to see if their regulation of circulating PTH molecular forms is normal. Compared to healthy subjects, the patients were hypercalcemic (p < 0.05) and had higher levels of PTH in all three assays (p < 0.001). Following the oral calcium load, serum-ionized calcium increased by 0.08 +/- 0.03 mmol/l in the patients and by 0.07 +/- 0.03 mmol/l in the healthy subjects after 90 min, whereas serum intact PTH, C-terminal PTH and N-terminal PTH were reduced, both in the healthy subjects and in the patients. Suppression by calcium of both intact PTH and C-terminal PTH were impaired in the patients (p < 0.05 and p < 0.001), whereas suppression of N-terminal PTH was normal. Furthermore, the C/i and N/i ratios were higher at the highest calcium concentration achieved after calcium intake in the healthy subjects than in the basal state in the patients (p < 0.05), in spite of the larger degree of hypercalcemia in the latter (1.40 +/- 0.06 vs. 1.31 +/- 0.02 mmol/l; p < 0.05). Thus, (1) a minor increase in serum-ionized calcium that is seen during daily life alters the relative circulating concentrations of PTH versus its fragments; (2) the impaired sensitivity to calcium in pHPT is not evident for the suppression of N-terminal PTH, and (3) pHPT is accompanied by altered immunoheterogeneity of circulating PTH.

摘要

为研究日常生活中出现的血清离子钙浓度轻度升高对循环甲状旁腺激素(PTH)免疫异质性的可能影响,我们采用序列特异性PTH检测法,测定了7名健康受试者口服1.5g钙后血清完整PTH、C端PTH和N端PTH的水平。我们还对10名原发性甲状旁腺功能亢进症(pHPT)患者进行了同样的检测,以观察他们对循环PTH分子形式的调节是否正常。与健康受试者相比,患者血钙过高(p < 0.05),且在所有三种检测中PTH水平均较高(p < 0.001)。口服钙负荷后,90分钟时患者血清离子钙升高了0.08±0.03mmol/L,健康受试者升高了0.07±0.03mmol/L,而健康受试者和患者的血清完整PTH、C端PTH和N端PTH均降低。患者中钙对完整PTH和C端PTH的抑制作用受损(p < 0.05和p < 0.001),而N端PTH的抑制作用正常。此外,尽管患者的高钙血症程度更高(1.40±0.06 vs. 1.31±0.02mmol/L;p < 0.05),但健康受试者在摄入钙后达到的最高钙浓度时的C/i和N/i比值高于患者的基础状态(p < 0.05)。因此,(1)日常生活中出现的血清离子钙轻度升高会改变PTH与其片段的相对循环浓度;(2)pHPT中对钙的敏感性受损在N端PTH的抑制方面不明显;(3)pHPT伴有循环PTH免疫异质性的改变。

相似文献

1
Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.血清钙轻微升高对健康受试者和原发性甲状旁腺功能亢进患者甲状旁腺激素免疫异质性的影响。
Horm Res. 1995;43(6):294-9. doi: 10.1159/000184315.
2
Immunoheterogeneity of parathyroid hormone pre- and postoperatively in primary hyperparathyroidism.原发性甲状旁腺功能亢进症患者甲状旁腺激素术前及术后的免疫异质性
Langenbecks Arch Chir. 1995;380(2):119-24. doi: 10.1007/BF00186419.
3
Immunoheterogeneity of parathyroid hormone after surgery for primary hyperparathyroidism.
Clin Chim Acta. 1994 Dec 16;231(2):139-45. doi: 10.1016/0009-8981(94)90198-8.
4
Suppression by calcium of serum levels of intact parathyroid hormone in patients with primary hyperparathyroidism.钙对原发性甲状旁腺功能亢进患者血清中完整甲状旁腺激素水平的抑制作用。
Horm Res. 1993;39(3-4):146-51. doi: 10.1159/000182715.
5
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
6
Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.正常血钙型原发性甲状旁腺功能亢进症、原发性甲状旁腺功能亢进症和健康受试者口服蛋白胨负荷和口服钙负荷对 PTH 的不同反应。
Eur J Endocrinol. 2012 Oct;167(4):491-7. doi: 10.1530/EJE-12-0362. Epub 2012 Aug 7.
7
Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions.甲状旁腺激素的羧基末端片段在原发性甲状旁腺功能亢进症中并不像在其他高钙血症情况下那样优先分泌。
J Clin Endocrinol Metab. 1993 Aug;77(2):413-9. doi: 10.1210/jcem.77.2.8345045.
8
Intact parathyroid hormone in primary hyperparathyroidism.
Br J Surg. 1990 Feb;77(2):168-72. doi: 10.1002/bjs.1800770217.
9
Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.
J Clin Endocrinol Metab. 1990 Apr;70(4):951-6. doi: 10.1210/jcem-70-4-951.
10
The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration.
J Clin Endocrinol Metab. 1992 Mar;74(3):525-32. doi: 10.1210/jcem.74.3.1740486.